Neuroblastoma, Wilms' Tumors and Other Pediatric Cancers
City of Hope offers comprehensive, family-centered and leading-edge treatment for childhood, adolescent and young adult (AYA) patients with neuroblastoma, Wilms' tumor and a wide variety of other benign and malignant solid tumors that require expert care for the best chance of a cure.
Neuroblastoma is cancer that develops in immature nerve cells, representing a diagnostic and treatment dilemma that requires expert knowledge of the tumor’s biology. At City of Hope, our ground-breaking work in laboratory science and patient care gives us the experience to determine whether the individual diagnosis calls for observation or the most aggressive approach.
When you come to City of Hope, you automatically gain access to an unparalleled array of support services to help you and your loved ones take each step during and after treatment.
City of Hope is a nationally recognized leader in researching and treating neuroblastoma, Wilms' tumors, and other pediatric cancers. We have been named a best hospital for cancer by U.S. News & World Report for over a decade.
As a founding member of the National Comprehensive Cancer Network, our doctors also help develop and improve evidence-based cancer treatment guidelines for patients throughout the country.
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.
Our developments in the areas of breakthrough cancer drugs, bone marrow transplants and CAR T cell therapy are recognized internationally.
Our leadership in research and innovation continually enhances our ability to provide novel and differentiated approaches to cancer care.
Jeanelle Folbrecht, Ph.D., psychologist | City of Hope, California
Natalie Kelly, Ph.D. is assistant clinical professor of psychology and clinical neuropsychologist in the Department of Supportive Care Medicine.